|
2
|
Haftchenary S, Nelson SD, Furst L, Dandapani S, Ferrara SJ, Bošković ŽV, Figueroa Lazú S, Guerrero AM, Serrano JC, Crews DK, Brackeen C, Mowat J, Brumby T, Bauser M, Schreiber SL, Phillips AJ. Efficient Routes to a Diverse Array of Amino Alcohol-Derived Chiral Fragments. ACS COMBINATORIAL SCIENCE 2016; 18:569-74. [PMID: 27518324 PMCID: PMC5022782 DOI: 10.1021/acscombsci.6b00050] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/06/2016] [Revised: 07/18/2016] [Indexed: 12/12/2022]
Abstract
Efficient syntheses of chiral fragments derived from chiral amino alcohols are described. Several unique scaffolds were readily accessed in 1-5 synthetic steps leading to 45 chiral fragments, including oxazolidinones, morpholinones, lactams, and sultams. These fragments have molecular weights ranging from 100 to 255 Da and are soluble in water (0.085 to >15 mM).
Collapse
Affiliation(s)
- Sina Haftchenary
- Center
for the Science of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
- Department
of Chemistry and Chemical Biology, Harvard
University, 12 Oxford
Street, Cambridge, Massachusetts 02138, United States
| | - Shawn D. Nelson
- Center
for the Science of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
- Department
of Chemistry and Chemical Biology, Harvard
University, 12 Oxford
Street, Cambridge, Massachusetts 02138, United States
| | - Laura Furst
- Center
for the Science of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
| | - Sivaraman Dandapani
- Center
for the Science of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
| | - Steven J. Ferrara
- Center
for the Science of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
| | - Žarko V. Bošković
- Center
for the Science of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
- Department
of Chemistry and Chemical Biology, Harvard
University, 12 Oxford
Street, Cambridge, Massachusetts 02138, United States
| | - Samuel Figueroa Lazú
- Center
for the Science of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
| | - Adrian M. Guerrero
- Center
for the Science of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
| | - Juan C. Serrano
- Center
for the Science of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
| | - DeMarcus K. Crews
- Center
for the Science of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
| | - Cristina Brackeen
- Center
for the Science of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
| | - Jeffrey Mowat
- Bayer
Pharma AG, Drug Discovery, Müllerstraße, 178, 13353 Berlin, Germany
| | - Thomas Brumby
- Bayer
Pharma AG, Drug Discovery, Müllerstraße, 178, 13353 Berlin, Germany
| | - Marcus Bauser
- Bayer
Pharma AG, Drug Discovery, Müllerstraße, 178, 13353 Berlin, Germany
| | - Stuart L. Schreiber
- Center
for the Science of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
- Department
of Chemistry and Chemical Biology, Harvard
University, 12 Oxford
Street, Cambridge, Massachusetts 02138, United States
- Howard
Hughes Medical Institute, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
| | - Andrew J. Phillips
- Center for
the Development of Therapeutics, Broad Institute, 415 Main Street, Cambridge, Massachusetts 02142, United States
| |
Collapse
|